from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3527/-

LFCtreatmentdescriptionclass of inhibitor

1.013

Amikacinug/mL Amikacintranslation

0.250

Cap5-10ug/mL Capreomycintranslation

1.552

Rox10-50 ug/mL Roxithromycintranslation

1.697

SM2-5 ug/mL Streptomycintranslation

0.762

Tet5-10 ug/mL Tetracyclinetranslation

-1.239

Rif0.2-5ug/mL Rifampicintranscription

-0.415

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.942

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.172

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.765

CPZ10-50 ug/mL Chlorpromazinerespiration

0.669

Clofazimine10-13 ug/mL Clofaziminerespiration

0.001

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.430

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.066

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.108

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.453

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.921

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.561

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.401

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.790

KCN5-20 ug/mL Potassium cyaniderespiration

-0.712

NaN30.2-2 mM Sodium aziderespiration

0.029

Nigericin50 uM Nigericinrespiration

0.368

TRC10-150 ug/mL Triclosanrespiration

0.732

TRZ10-25 ug/mL Thioridazinerespiration

1.378

Valinomycin0.5-10 uM Valinomycinrespiration

-1.595

ZnSO42 mM ZnSO4respiration

2.274

menadione6-10 ug/mL Menadionerespiration

3.224

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.620

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.401

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.112

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.231

NRP_1Non-replicating persistence stage 1dosRassociated

-0.312

Amp0.2mg/mL AmpicillincellWall

-0.810

Cephalexin20-100 ug/mL CephalexincellWall

-0.369

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.399

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.550

EMB10-20 ug/mL EthambutolcellWall

-0.563

Eta12-40 ug/mL EthionamidecellWall

-0.709

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.259

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.707

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.893

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.014

BZA0.12 mg/mL BenzamidearomaticAmides

-0.308

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.335

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.806

H2O24 mM hydrogen peroxideDNAdamaging

-0.483

Levo10 ug/mL LevofloxacinDNAdamaging

-0.664

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.341

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.350

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.272

UVUV-irradiationDNAdamaging

0.479

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.522

Antimycin12.5-50 ug/mL Antimycin A?

-0.580

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.159

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.226

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.332

PA8240.2-2 ug/mL PA-824?

0.356

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.764

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.114

Verapamil50 uM Verapamil?

-0.503

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.383

methoxatin10-20 ug/mL Methoxatin?